Acticoat

Acticoat®

A proprietary silver nitrate-based antibacterial burn dressing for wound protection.

Acticoat™

Wound care A silver nitrate-based antibacterial burn dressing for wound protection. See Pressure ulcer.
Mentioned in ?
References in periodicals archive ?
Clean burn wounds with a TBSA > 10% up to a depth of superficial partial thickness have increasingly been covered with Biobrane and Acticoat dressings within the first 24 hours after burn injury.
Mortality in paediatric burns victims: a retrospective review from 2009 to 2012 in a single centre
Managing chronic wounds with Acticoat Moisture Control.
Beneficial effects of silver foam dressing on healing of wounds with ulcers and infection control of burn patients
Yin, HQ, Langford, R, Burrell, RE, "Comparative Evaluation of the Antimicrobial Activity of ACTICOAT Antimicrobial Barrier Dressing.
Coatings with metallic effect pigments for antimicrobial and conductive coating of textiles with electromagnetic shielding properties
The nanocrystals in the firm's Acticoat product line release silver ions in the dressing and sustain release for up to seven days, killing such virulent germs as MRSA (methicillin-resistant Staphylococcus aureus) and VRE (vancomycin resistant enteroccocus).
Thinking small: the promise of nanotechnology could potentially lead to new classes of medical devices and pharmaceuticals
Silver coated ressing Acticoat caused raised liver enzymes and argyria-like symptoms in burn patient.
Nanoparticulas de plata: aplicaciones y riesgos toxicos para la salud humana y el medio ambiente
Earlier this year, an in-vitro laboratory study conducted by Smith & Nephew, a global medical technology company located in London, England, indicated that a silver-coated antimicrobial dressing, ACTICOAT, could kill organisms that were recognized as among the most difficult to treat for antibiotic-resistant organisms, often referred to as "superbugs.
Silver Aiding New Medical Technologies
Acticoat dressings and major burns: systemic silver absorption.
In vivo effect of silver nanoparticles on serum ALT, AST and ALP activity in male and female mice
In 2001, Westaim sold Acticoat to Smith & Nephew, a U.
Bandage solution: a Canadian company is using its unique expertise in silver chemistry to create a new line of wound care products
A randomized comparative trial between acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis.
Topical effectiveness of different concentrations of nanosilver solution on Leishmania major lesions in Balb/c mice
Commercially available silver coated dressings, such as Acticoat, have been developed for the treatment and prevention of MRSA infection (Ulkur et al 2005, Ip et al 2006, Lee et al 2010).
The role of perioperative care in reducing rates of methicillin resistant Staphylococcus aureus
The role of Acticoat with nanocristalline silver in the management of burns.
Profilaxis antibiotica en quemaduras
Since 2001, Smith & Nephew has held exclusive license for the sale of the ACTICOAT dressing portfolio, manufactured at the Ft.
Smith & Nephew acquires all assets of Nucryst Pharmaceuticals

Medical browser ?
Full browser ?